Research Article
Real-World Study of Cisplatin, Etoposide, and Bleomycin Chemotherapy Regimen in Gestational Trophoblastic Neoplasia
Table 2
Efficacy of BEP chemotherapy in GTN patients (
).
| | N (percentile) | Primary treatment group () | Salvage treatment group () |
| | Course of BEP | 4 (3, 5) | 3 (2, 4) | | Additional treatment | 15 (22.7) | 10 (34.5) | | Hysterectomy | 12 (18.2) | 6 (20.7) | | UAE | 3 (4.5) | 0 (0) | | Radiation | 1 (1.52) | 1 (3.4) | | Lobectomy | 0 (0) | 2 (6.9) | | Hysteroscopic lesion resection | 0 (0) | 1 (3.4) | | Response | | | | CR | 58 (87.9) | 24 (82.8) | | PR | 8 (12.1) | 5 (17.2) | | Reasons to change BEP regimen | 17 (25.8) | 8 (27.6) | | Resistance | 8 (12.1) | 5 (17.2) | | Nontolerable | 3 (4.5) | 3 (10.3) | | Strengthen for no bleomycin or restriction | 6 (9.1) | 0 (0) |
|
|
Note: BEP: cisplatin, etoposide, and bleomycin; GTN: gestational trophoblastic neoplasia; UAE: uterine artery embolism; CR: complete remission; PR: partial remission. |
